Take the Dry Eye Quiz

Should You Get Screened for Chronic Dry Eye Disease?

Take this quiz to help determine if you may have a type of Chronic Dry Eye disease. After taking the quiz, share your results with an eye doctor and ask to get screened.


  1. I use artificial tears often (also known as over-the-counter lubricant eye drops).
    True False

    Approximately how often?
    Less than daily
    1 to 2 times per day
    3 or more times per day


  2. I usually carry artificial tears with me wherever I go.
    True False

  3. I have been using artificial tears for a long time.
    True False

    Approximately how long?
    Less than 1 year
    1 to 2 years
    More than 2 years


  4. I have tried multiple types of over-the-counter artificial tears.
    True False

    What types? (Check all that apply.)
    Lubricant eye drops (over-the-counter artificial tears)
    Lubricant eye gel (artificial tear in the form of a gel)
    Lubricant eye ointment (artificial tear in the form of an ointment)
    Contact lens rewetting eye drops

  5. My dry eyes are getting worse.
    True False

  6. Dry eyes affect my daily activities.
    True False

    Approximately how often?
    Less than daily
    Parts of the day
    All day


I would like to have the results e-mailed to me.

To have your personal results e-mailed to you, please complete the information below.

*Required information











*Yes, I would like to receive information about RESTASIS® and other products and disease states from Allergan. I understand that I can opt-out of receiving e-mails at any time by clicking the unsubscribe link in any e-mail.


Sign up for the chance to participate in market research.

Allergan occasionally engages third-party firms to conduct consumer-based market research studies about our products or the health conditions they treat. By checking this box and opting in and providing the requested information, you are agreeing to be contacted about future research opportunities. Your information will only be used for the purpose of market research and will not be sold or distributed to any outside party for any other use.

See Allergan's Privacy Statement.


 

Approved Use

RESTASIS® and RESTASIS MultiDose™ Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose™ did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose™ Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose™ should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose™ and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose.

Dr. Tendler is an actual RESTASIS® patient and is compensated for appearing on this website.

†Up to a $250 savings on three 5.5 mL bottles or a 90-day supply of single-dose vials. Patients whose prescriptions will be paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program are not eligible for savings or rebates according to federal and state law.

The actual savings on your out-of-pocket costs for RESTASIS MultiDose™ will vary according to refill quantity and personal healthcare insurance coverage. Please review the My Tears, My Rewards® program guidelines to learn more.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169 09/17   © 2017 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.

Approved Use

RESTASIS® and RESTASIS MultiDose™ Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose™ did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose™ Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose™ should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose™ and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose.

Dr. Tendler is an actual RESTASIS® patient and is compensated for appearing on this website.

†Up to a $250 savings on three 5.5 mL bottles or a 90-day supply of single-dose vials. Patients whose prescriptions will be paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program are not eligible for savings or rebates according to federal and state law.

The actual savings on your out-of-pocket costs for RESTASIS MultiDose™ will vary according to refill quantity and personal healthcare insurance coverage. Please review the My Tears, My Rewards® program guidelines to learn more.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169 09/17   © 2017 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.